Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of KAI-1678 to Treat Subjects With Postoperative Pain
This study has been completed.
Study NCT01015235   Information provided by KAI Pharmaceuticals

First Received on November 16, 2009.   Last Updated on August 31, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pain, Postoperative
More general conditions related to this trial
Pain
Pathologic Processes
Postoperative Complications
Signs and Symptoms
Interventions listed in this trial
Placebo
KAI-1678
Ketorolac Tromethamine
Additional drug interventions recognized in this trial
Ketorolac
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
KAI Pharmaceuticals
Trident Clinical Research Pty Ltd


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services